What Researchers Did
Researchers tested apolipoprotein E (APOE) genotypes in 86 carbon monoxide-poisoned patients from a randomized trial to assess the epsilon4 allele's effect on 6-week cognitive sequelae and its interaction with hyperbaric or normobaric oxygen treatment.
What They Found
Among 86 patients, 31 (36%) had at least one epsilon4 allele. Six-week cognitive sequelae rates for HBO2-treated patients were 11% (3/27) without the epsilon4 allele and 35% (6/17) with it, compared to NBO2-treated patients at 43% (12/28) without and 29% (4/14) with the allele. The interaction between the epsilon4 allele and treatment was significantly associated with 6-week cognitive sequelae (P = 0.048).
What This Means for Canadian Patients
Canadian patients experiencing carbon monoxide poisoning might benefit from hyperbaric oxygen therapy, with treatment decisions potentially informed by their APOE epsilon4 genotype. This genetic information could help tailor interventions to reduce the risk of cognitive problems.
Canadian Relevance
There is no direct Canadian connection mentioned in this study.
Study Limitations
The study was limited by a relatively small sample size of genotyped patients and the abstract does not provide a complete conclusion or full details on all potential confounding factors.